All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YJ078 | Anti-LHX6 (2A2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2A2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ578 | Anti-LHX6 (2A2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2A2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-0320ZP1431 | Anti-LHX6 (DS2053AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DS2053AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1432 | Anti-LHX6 (DS2053AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | DS2053AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1433 | Anti-LHX6 (3D9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3D9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1434 | Anti-LHX6 (3D9) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 3D9 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1436 | Anti-LHX6 (2A2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 2A2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1437 | Anti-LHX6 (1B11) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1438 | Anti-LHX6 (1B11) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1B11 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1439 | Anti-LHX6 (3E8) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3E8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1440 | Anti-LHX6 (3E8) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 3E8 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION